A few things to keep in mind while reading: side effect percentages come from different clinical trials with different populations, durations, and designs, so direct comparisons have limitations
The potential mechanisms through which GLP-1 and GIP/GLP-1 receptor agonists recalibrate and normalize the fat mass and body weight setpoint in patients with obesity may stem from their primary effects on incretin homeostasis
Yet for those with heart or kidney complications, the shift toward agents with broader benefits is well underway
Procedures such as gastric bypass or sleeve gastrectomy have demonstrated significant long-term weight loss and improvement in obesity-related comorbidities, though patients require lifelong monitoring including thyroid function assessment, as malabsorption may affect levothyroxine requirements
As a registered dietitian, I was curious to better understand what's actually in the product, what the research does and doesn't show and who Pendulum's products may be a good fit for